In 2024, Germany and South Korea lead global musculo-skeletal system medicine sales, reaching $1.71B and $1.55B respectively. Australia's market is notable for rapid growth, despite being smaller at $0.4577B. Switzerland follows at $0.4534B. Smaller markets like Latvia and Estonia are experiencing robust growth, seen in recent increases of 4.63% and 5.95%. In contrast, Croatia and Chile show declines with -0.28% and -2.6% respectively. In the past five-year CAGR, Slovakia and Estonia displayed significant upticks, while New Zealand faced downtrends, with -5.94% last year.
Future trends to watch involve emerging technology integration and personalized medicine adaptations, likely to drive regional market shifts, emphasizing patient-specific medical solutions and digital health advances.
Top countries in Musculo-Skeletal System Medicine Sales by Country
| # | 10 Countries | Million US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 1,710 | 2023 | +1.26% | +2.26% | View data |
| 2 | 2 South Korea | 1,550 | 2023 | +2.43% | +2.25% | View data |
| 3 | 3 Australia | 457.7 | 2023 | +2.12% | +4.14% | View data |
| 4 | 4 Switzerland | 453.4 | 2023 | +5.08% | +1.18% | View data |
| 5 | 5 Croatia | 382.2 | 2023 | +1.89% | -0.28% | View data |
| 6 | 6 Belgium | 253.8 | 2023 | -0.63% | -1.92% | View data |
| 7 | 7 Sweden | 204.4 | 2023 | +4.18% | +0.29% | View data |
| 8 | 8 Portugal | 185.6 | 2023 | -0.16% | -0.48% | View data |
| 9 | 9 Chile | 166 | 2023 | +11.94% | -2.6% | View data |
| 10 | 10 Slovakia | 134.8 | 2023 | +3.06% | +6.24% | View data |
